PDSB icon

PDS Biotechnology
PDSB

Overview Fund Activity

47 hedge funds and large institutions have $15.4M invested in PDS Biotechnology in 2022 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 14 increasing their positions, 11 reducing their positions, and 13 closing their positions.

Holders
47
Holders Change
-4
Holders Change %
-7.84%
% of All Funds
0.81%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
14
Reduced
11
Closed
13
Calls
$2.05M
Puts
$241K
Net Calls
+$1.81M
Net Calls Change
+$144K

Top Buyers

1
LPL Financial
1
LPL Financial
California
$1.47M
2
Citadel Advisors
2
Citadel Advisors
Florida
$353K
3
IGGA
3
Iron Gate Global Advisors
Utah
$223K
4
Jacobs Levy Equity Management
4
Jacobs Levy Equity Management
New Jersey
$171K
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$3.41M

Top Sellers

1
Millennium Management
1
Millennium Management
New York
$0
2
Two Sigma Investments
2
Two Sigma Investments
New York
$886K
3
Two Sigma Advisers
3
Two Sigma Advisers
New York
$1.23M
4
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$176K
5
Renaissance Technologies
5
Renaissance Technologies
New York
$957K
Name Holding Trade Value Shares
Change 		Shares
Change %
TI
51
Trexquant Investment
Connecticut
– -$55K -15,151 Closed
Simplex Trading
52
Simplex Trading
Illinois
– -$49K -13,426 Closed
Cetera Investment Advisers
53
Cetera Investment Advisers
Illinois
– -$40K -10,865 Closed
QT
54
Quantbot Technologies
New York
– -$15K -4,200 Closed
TCWM
55
Total Clarity Wealth Management
Illinois
– -$14K -3,779 Closed
National Bank of Canada
56
National Bank of Canada
Quebec, Canada
– -$8K -2,200 Closed
CG
57
Cutler Group
California
– -$2K -800 Closed
CAPTRUST Financial Advisors
58
CAPTRUST Financial Advisors
North Carolina
– -$1K -250 Closed
1 2
3